Submit a Letter of Intent for MICHR’s Clinical and Translational Science Pilot Award

Published on July 31, 2025
Clinical and Translational Science Pilot Award

Are you interested in developing innovative solutions that will ultimately benefit research across a range of diseases and health conditions? To advance these efforts, the Michigan Institute for Clinical & Health Research is offering the Clinical and Translational Science Pilot Award. This funding is intended to support investigators in developing novel solutions and strategies that overcome common scientific and operational roadblocks in translational research.

Projects should propose addressing a common cause of inefficiency or failure in research projects at any stage of translation (T1-T4). Many of these causes are shared across targets, diseases, and therapeutic areas; therefore, outcomes are expected to produce foundational knowledge that will increase the efficiency and effectiveness of translational research and ultimately improve health.

Faculty members with primary appointments at U-M; Michigan Medicine affiliate physicians (i.e., U-M Health West and Sparrow); and U-M staff are eligible to serve as Principal Investigators. Community partners and patient advisors are eligible to serve as Co-PIs.

A brief Letter of Intent (LOI) is required and can be submitted via UMMS Competition Space by August 25, 2025. Those with responsive LOIs will be invited to submit a full application.

To learn more about this funding opportunity:

  • View a recording of the CTS Pilot Award informational webinar here.
  • Sign up for an office hour appointment to receive personalized feedback on your Clinical & Translational Science Pilot project idea. Click here to schedule.
  • Visit our website for LOI guidelines and additional information here.

If you have questions, please email the MICHR Pilot Grant Program at [email protected].